Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pDest490-OPN-a Citations (3)

Originally described in: An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.
Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang XW Oncogene. 2007 Sep 27. 26(44):6361-71.
PubMed Journal

Articles Citing pDest490-OPN-a

Articles
Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome. Takeyari S, Yamamoto T, Kinoshita Y, Fukumoto S, Glorieux FH, Michigami T, Hasegawa K, Kitaoka T, Kubota T, Imanishi Y, Shimotsuji T, Ozono K. Bone. 2014 Oct;67:56-62. doi: 10.1016/j.bone.2014.06.026. Epub 2014 Jun 27. PubMed
Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia. Kinoshita Y, Hori M, Taguchi M, Fukumoto S. Bone. 2014 Oct;67:145-51. doi: 10.1016/j.bone.2014.07.009. Epub 2014 Jul 12. PubMed
Osteopontin as a novel substrate for the proprotein convertase 5/6 (PCSK5) in bone. Hoac B, Susan-Resiga D, Essalmani R, Marcinkiweicz E, Seidah NG, McKee MD. Bone. 2018 Feb;107:45-55. doi: 10.1016/j.bone.2017.11.002. Epub 2017 Nov 7. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.